Overall result forecast presentation:	yes
Quantity performed reporting year:	15
Quantity forecast year:	14
Examination by state associations?	yes
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	50
Quantity forecast year:	43
Examination by state associations?	yes
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ07	Measures for quality assurance in the care of pre-term and full-term neonates – perinatal focus

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: yes

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
92	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
59	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
52	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Handbuch zum Risikomanagement

01.03.2017

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Handbuch zum Risikomanagement

01.03.2017

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
Verwendung spezieller Software (Zenzy®)

Electronic support for the supply of patients with drugs

Elektronisches Bestellwesen

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung des Medikationsplans
Umsetzung des Rahmenvertrages zum Entlassmanagement

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Priv.-Doz. Dr. med. Martin Eicke - Johannes Gutenberg-Universität Mainz/ Neurologie Prof. Dr. med. Eva Möhler - Universität Heidelberg Pädagogische Hochschule/ Kinder- und Jugendpsychiatrie

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL04 - Project-related cooperation with colleges and universities

Explanation

FL09 - Doctoral supervision

Explanation

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

HB02 - Health and paediatric nurse (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 5
- Additional staff: 4

Service contact persons

Patient advocates

Elfi Retzler

Patientenfürsprecherin

Dr.-Ottmar-Kohler-Straße 2
55743 Idar-Oberstein

Phone: 06781-66-1701
Mail: ed.nekinilk-ghs.oi@rehcerpsreufnetneitap

Customer feedback management

Francesca Stein

Ansprechpartnerin Ideen- und Beschwerdemanagement

Dr.-Ottmar-Kohler-Straße 2
55743 Idar-Oberstein

Phone: 06781-66-1701
Mail: ed.nekinilk-ghs.oi@gnuniem.eniem

Quality management

Jens Wagenknecht

Qualitätsmanagementbeauftragter/ Qualitätsmanagement & Organisationsentwicklung, Risikomanagement, Zertifizierung und Zentrenbildung, Zufriedenheitserhebungen

Dr.-Ottmar-Kohler-Straße 2
55743 Idar-Oberstein

Phone: 06781-66-1963
Mail: ed.nekinilk-ghs.oi@tnemeganamsteatilauq

Hygiene officer

Dr. med. Michael Gesemann

Hygienebeauftragter Arzt

Dr.-Ottmar-Kohler-Straße 2
55743 Idar-Oberstein

Phone: 06781-66-1646
Mail: ed.nekinilk-ghs.oi@nnameseg.m

Responsible for drug therapy

Dr. Claudia Lamberth

Leitende Apothekerin

Dr.-Ottmar-Kohler-Straße 2
55743 Idar-Oberstein

Phone: 06781-66-1780
Mail: ed.nekinilk-ghs.oi@ekehtopa